Adolescents and young adults with preexisting autoimmune disease are more likely to develop type 1 diabetes than those ...

From the "pot-bellied" appearance to the flaws in the LDDST, Cushing's disease remains one of our most complex endocrine ...

Among postmenopausal women, hormone therapy (HT) use is associated with an increased incidence and risk for developing autoimmune disease.

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are associated with a reduced risk for autoimmune rheumatic diseases.

The European Society for Endocrinology (ESE) and the European Society for Paediatric Endocrinology (ESPE) have released today ...

The obesity rate for adults in the U.S. dropped to 37% in 2025 after peaking at 39.9% in 2022, but diabetes has reached an ...

Pregnancy complications such as gestational diabetes mellitus (GDM), preeclampsia, and gestational hypertensive disorders are becoming increasingly ...

The company reported its second late-stage study success, this time with a drug that could become a new treatment standard ...

Based on the DESTINY-Breast06 phase III trial results demonstrating statistically significant and clinically meaningful progression-free survival benefit in patients treated with Enhertu vs.

Attendees can take advantage of free health screenings, learn practical tips for diabetes management, and connect directly ...

Lipid biomarkers, including common measures such as cholesterol and triglycerides as well as newer indicators like lipoproteins, apolipoproteins, and ...

Endocrine therapy typically slows cell cycle progression by reducing cyclin D1, which partners with CDK4/6 to promote cell ...